Aberrantly expressed MUC4 can act as a ligand for ERBB2, potentiate the phosphorylation of ERBB2, and reduce the binding of anti-ERBB2 antibodies to tumor cell surfaces [24]. The gene discussed is MUC4; the disease is neoplasm.